These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 232623)

  • 1. Mechanism of resistance of mice to syngeneic methylcholanthrene induced fibrosarcomas.
    Nelson DS; Nelson M; Hopper KE
    Adv Exp Med Biol; 1979; 121B():541-52. PubMed ID: 232623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
    Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular origin of blocking factors from cultured spleen cells of tumor-bearing mice.
    Koppi TA; Halliday WJ
    Cell Immunol; 1983 Feb; 76(1):29-38. PubMed ID: 6131747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of delayed-type hypersensitivity and resistance against allogeneic or syngeneic methylcholanthrene-induced tumors in mice preimmunized with the tumor extracts.
    Tamura S; Kojima A; Egashira Y
    Jpn J Med Sci Biol; 1979 Dec; 32(6):353-66. PubMed ID: 544868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of suppressor cells by a tumor-derived suppressor factor.
    Jessup JM; Le Grue SJ; Kahan BD; Pellis NR
    Cell Immunol; 1985 Jun; 93(1):9-25. PubMed ID: 3158410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophages and lymphoid tissues in mice with concomitant tumour immunity.
    Nelson DS; Kearney R
    Br J Cancer; 1976 Sep; 34(3):221-6. PubMed ID: 973997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss.
    Halliday WJ
    Cell Immunol; 1972 Jan; 3(1):113-22. PubMed ID: 5061636
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.
    Kearney R; Wu RL; Orr F
    Br J Cancer; 1979 Jun; 39(6):648-58. PubMed ID: 444404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific augmentation of delayed-type hypersensitivity by immune serum factor in mice: augmentation of anti-tumor cytostatic activity.
    Nakamura S; Himeno K; Yamada A; Mitani M; Nomoto K
    Cell Immunol; 1986 Dec; 103(2):311-25. PubMed ID: 3542236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of radiation on tumor-specific delayed-type hypersensitivity (DTH) response in mice].
    Kawahara S; Hashimoto T; Hachisu R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):675-80. PubMed ID: 2798059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
    Elgert KD; Farrar WL
    J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.